These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26961969)

  • 21. Self nano-emulsifying simvastatin based tablets: design and in vitro/in vivo evaluation.
    Abdelbary G; Amin M; Salah S
    Pharm Dev Technol; 2013; 18(6):1294-304. PubMed ID: 22468935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A top-down technique to improve the solubility and bioavailability of aceclofenac: in vitro and in vivo studies.
    Narayan R; Pednekar A; Bhuyan D; Gowda C; Koteshwara KB; Nayak UY
    Int J Nanomedicine; 2017; 12():4921-4935. PubMed ID: 28744125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation.
    Lei Y; Kong Y; Sui H; Feng J; Zhu R; Wang W
    Drug Deliv Transl Res; 2016 Oct; 6(5):519-25. PubMed ID: 27206446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
    Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
    Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
    Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Characterization of Venetoclax Nanocrystals for Oral Bioavailability Enhancement.
    Kala SG; Chinni S
    AAPS PharmSciTech; 2021 Mar; 22(3):92. PubMed ID: 33683477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uniform nano-sized valsartan for dissolution and bioavailability enhancement: influence of particle size and crystalline state.
    Ma Q; Sun H; Che E; Zheng X; Jiang T; Sun C; Wang S
    Int J Pharm; 2013 Jan; 441(1-2):75-81. PubMed ID: 23266761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aceclofenac nanocrystals with enhanced in vitro, in vivo performance: formulation optimization, characterization, analgesic and acute toxicity studies.
    Rahim H; Sadiq A; Khan S; Khan MA; Shah SMH; Hussain Z; Ullah R; Shahat AA; Ibrahim K
    Drug Des Devel Ther; 2017; 11():2443-2452. PubMed ID: 28860715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
    Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
    Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of Nanonized Nitrendipine and Its Transformation into Nanoparticulate Oral Fast Dissolving Drug Delivery System.
    Gandhi NV; Deokate UA; Angadi SS
    AAPS PharmSciTech; 2021 Mar; 22(3):113. PubMed ID: 33751276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets.
    Patel J; Dhingani A; Garala K; Raval M; Sheth N
    Drug Deliv; 2014 Sep; 21(6):412-35. PubMed ID: 24215334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, Optimization, and Evaluation of Lurasidone Hydrochloride Nanocrystals.
    Shah S; Parmar B; Soniwala M; Chavda J
    AAPS PharmSciTech; 2016 Oct; 17(5):1150-8. PubMed ID: 26586537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperoside nanocrystals for HBV treatment: process optimization, in vitro and in vivo evaluation.
    Shen B; Wu N; Shen C; Zhang F; Wu Y; Xu P; Zhang L; Wu W; Lu Y; Han J; Wang Y; Yuan H
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1772-81. PubMed ID: 27032257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bicalutamide nanocrystals with improved oral bioavailability: in vitro and in vivo evaluation.
    Pokharkar VB; Malhi T; Mandpe L
    Pharm Dev Technol; 2013; 18(3):660-6. PubMed ID: 22394215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral fast-dissolving films containing lutein nanocrystals for improved bioavailability: formulation development, in vitro and in vivo evaluation.
    Liu C; Chang D; Zhang X; Sui H; Kong Y; Zhu R; Wang W
    AAPS PharmSciTech; 2017 Nov; 18(8):2957-2964. PubMed ID: 28462465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of Chronomodulated Drug Delivery System of Valsartan: In Vitro Characterization.
    Sokar M; Hanafy A; Elkamel A; El-Gamal S
    Indian J Pharm Sci; 2015; 77(4):470-7. PubMed ID: 26664064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Vitro and In Vivo Performance of Different Sized Spray-Dried Crystalline Itraconazole.
    Kumar S; Jog R; Shen J; Zolnik B; Sadrieh N; Burgess DJ
    J Pharm Sci; 2015 Sep; 104(9):3018-28. PubMed ID: 25195539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation of 20(S)-protopanaxadiol nanocrystals to improve oral bioavailability and brain delivery.
    Chen C; Wang L; Cao F; Miao X; Chen T; Chang Q; Zheng Y
    Int J Pharm; 2016 Jan; 497(1-2):239-47. PubMed ID: 26680316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation.
    Chen L; Wang Y; Zhang J; Hao L; Guo H; Lou H; Zhang D
    Eur J Pharm Biopharm; 2014 May; 87(1):160-9. PubMed ID: 24333772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulse release of doxazosin from hydroxyethylcellulose compression coated tablet: mechanistic and in vivo study.
    Biswas N; Guha A; Sahoo RK; Kuotsu K
    Int J Biol Macromol; 2015 Jan; 72():537-43. PubMed ID: 25179280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.